Lumacang, Ajijul Radzhata .

HRN: 26-19-90  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2024
AMPICILLIN 250MG (VIAL)
11/08/2024
11/15/2024
IV
250
Q6
URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaURTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: